In future studies, it will be interesting to determine the extent to which valproic acid, suberoylanilide hydroxamic acid or MS-275 can restore IFN-γ suppression of TRAIL-mediated signaling in RA-FLS. Here, IFNG is linked to rheumatoid arthritis.